Skip to main content
Skip to section navigation
Skip to footer
About Us
Company Overview
Management
Board of Directors
Pipeline
Pipeline Overview
Paxalisib
PD-L1 Protein Degrader
SETDB1 Inhibitor
EVT801
Clinical Trials
Posters & Publications
Technology
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Investors
Investors Overview
News & Events
Company Info
Financial Results
Stock Data
SEC Filings
Governance
ASX Delisting
Contact Us
ASX Announcements
Media Center
Media Center
Media Center Overview
News
Events
In The News
Video Gallery
ASX Announcements
Sep 11, 2023
Change in substantial holding
Aug 31, 2023
Appendix 4E and 2023 Annual Report
Aug 31, 2023
Appendix 4G
Aug 31, 2023
2023 Corporate Governance Statement
Aug 11, 2023
Kazia announces change to Board of Directors
Aug 11, 2023
Application for quotation of securities - KZA
Aug 11, 2023
Cleansing Notice
Aug 11, 2023
Cleansing Notice - updated
Aug 11, 2023
Final Director's Interest Notice - Iain Ross
Aug 1, 2023
Appointment of Dr John Friend as Managing Director
rss_feed
RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
…
Page
19
Next Page
arrow_forward
Select a page
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
